JT
Tamburini Bonnefoy, Jérôme
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma : a case report | Haematologica |  | 2026 | 5 | 23 | ||
| The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia | Blood advances | | 2025 | 77 | 154 | ||
| Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B-cell lymphoma : Insights from real-life clinical practice | Cancer reports | | 2024 | 69 | 505 | ||
| Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation | Leukemia | | 2024 | 37 | 40 | ||
| Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models | Science translational medicine |  | 2024 | 188 | 0 | ||
| Selective haematological cancer eradication with preserved haematopoiesis | Nature | | 2024 | 150 | 96 | ||
| AMPK activation induces immunogenic cell death in AML | Blood advances | | 2023 | 76 | 28 | ||
| Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia | Blood advances | | 2023 | 174 | 275 | ||
| Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia | Leukemia | | 2023 | 80 | 110 | ||
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma | Cell death and disease | | 2023 | 326 | 186 | ||
| An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML | Cancer discovery | | 2022 | 367 | 366 | ||
| RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia | Leukemia | | 2022 | 143 | 73 | ||
| T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | | 2022 | 264 | 138 | ||
| AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia | Cancers | | 2021 | 210 | 93 | ||
| Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia | Science advances | | 2015 | 212 | 259 | ||
| The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation | Blood | | 2010 | 226 | 493 |
